Olema Oncology partners with Pfizer for breast cancer drug trial
Go back to Olema Oncology partners with Pfizer for breast cancer drug trial| (NASDAQ: OLMA) | Delayed: 10.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.85 | 52 Week High | $ | |||
| Open | $10.85 | 52 Week Low | $ | |||
| Day High | $10.85 | P/E | N/A | |||
| Day Low | $10.85 | EPS | $ | |||
| Volume | 1 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.30 | 52 Week High | $37.39 | |||
| Open | $28.30 | 52 Week Low | $28.25 | |||
| Day High | $28.30 | P/E | 17.15 | |||
| Day Low | $28.30 | EPS | $1.65 | |||
| Volume | 131,042 | |||||

